Compass therapeutics to participate in upcoming september investor events

Boston, aug. 26, 2025 (globe newswire) -- compass therapeutics, inc. (“compass”) (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the following investor events during the month of september.
CMPX Ratings Summary
CMPX Quant Ranking